Why choose napo pharmaceuticals? Napo Pharmaceuticals, a wholly-owned subsidiary of San Francisco-based Jaguar Health, Inc., focuses on the development and commercialization of proprietary pharmaceuticals for the global marketplace — every country, every population, every channel — regardless of social or economic status.Is napo pharma selling their monis? I would say they are sells monis: Napo Pharma raises $2.1 mln net from convertible debt and share issues LONDON (Thomson Financial) - Napo Pharmaceuticals Inc. said it has raised around $2.1 million gross through the issue of convertible debt and shares.What is napo doing in developing countries? During the case study, Napo is developing compounds for sale in major Western markets, the organization of innovative public-private partnership to develop and distribute crofelemer in developing countries. In developing countries, the connection will treat diarrhea, which kills more than 2.5 million children every year.Does the fall in napos share price place an unrealistic value on napo? Lisa A. Conte CEO of Napo Pharmaceuticals, Inc. commented: "It is my firm belief that, the fall in the Company's share price places an unrealistic value on Napo and disregards the recently announced trial results.
Phone Number +114153718300 Napo Pharmaceuticals, Inc. develops and commercializes proprietary pharmaceuticals for international markets. It offers Crofelemer for gastrointestinal indications, including chronic diarrhea in persons living with HIV/AIDS; and NP-500, a product for insulin-resistant diseases.
Our Mission Napo Pharmaceuticals, a wholly-owned subsidiary of San Francisco-based Jaguar Health, Inc., focuses on the development and commercialization of proprietary pharmaceuticals for the global marketplace — every country, every population, every channel — regardless of social or economic status. Napo’s mission is to provide novel medicines to high-margin ...